Pfizer : PFE

All Pfizer Articles

1515 Articles

Paul Ausick | Apr 21, 2014 at 4:40 PM EDT

The 4 Stocks That Boosted Markets

thinkstockApril 21 2014: Markets opened higher on Monday but there wasn’t a lot of action as the only data out…

Jon C. Ogg | Apr 21, 2014 at 1:25 PM EDT

What a Combined Pfizer and AstraZeneca Would Look Like, and Face

ThinkstockIt is not that common that you hear about mergers in the $50 billion range. But what about when you…

Jon C. Ogg | Apr 16, 2014 at 10:40 AM EDT

Why Lpath Could Rise 300%

Canaccord Genuity is one of the few firms that are willing to cover small-cap biotech and emerging pharma stocks. Sometimes…

Paul Ausick | Apr 7, 2014 at 4:27 PM EDT

The 4 Stocks That Slammed the Market

thinkstockApril 7, 2014: Markets opened lower on Monday and were on a downhill slide all day long. Momentum stocks again…

Jon C. Ogg | Apr 7, 2014 at 11:00 AM EDT

FDA Keeps Driving Up Future Cost of Inhalable Insulin

While the FDA has been far from a friend to MannKind over the past few years, the latest FDA panel…

Paul Ausick | Apr 1, 2014 at 7:50 AM EDT

U.S. Companies Park $947 Billion Offshore

ThinkstockWhen the S&P 500 index rises more than 25% in a year, you have to figure that some of the…

Paul Ausick | Mar 26, 2014 at 9:05 AM EDT

Telecoms Liven Up Short Interest in Big Dividend Stocks

ThinkstockThe short interest data for the first two weeks of March is out, and the results among the top high-yield…

Trey Thoelcke | Mar 26, 2014 at 8:45 AM EDT

J.P. Morgan Says Buy Specialty and Big Pharmaceuticals Now

Wikimedia CommonsWith the U.S. pharmaceutical group, and particularly the specialty pharmaceutical names, under pressure over recent trading sessions, the large…

Paul Ausick | Mar 24, 2014 at 4:01 PM EDT

The 4 Stocks That Pushed Stocks Lower on Monday

thinkstockMarch 24, 2014: Markets opened slightly higher on Monday but soon took a turn south and spent most of the…

Paul Ausick | Mar 21, 2014 at 4:01 PM EDT

The 5 Stocks That Sank Markets on Friday

thinkstockMarch 21, 2014: Markets opened higher on Friday but the Nasdaq sank quickly, bounced for a while, and finally settled…

Jon C. Ogg | Mar 15, 2014 at 10:18 AM EDT

Analysts’ Top Dow Jones Industrial Dividend Stocks To Buy

After a rocky week where the markets were concerned about everything from Russia, slowing Chinese growth and why Malaysia Airlines Flight 370…

Trey Thoelcke | Mar 14, 2014 at 8:50 AM EDT

Jefferies’ Cheapest Health Care Stocks to Buy

In a new report out from Jefferies, the analysts posted a complete list of the cheapest, on a P/E basis,…

Paul Ausick | Mar 12, 2014 at 2:51 PM EDT

Pfizer Will Appeal Court Decision Regarding Celebrex Reissue Patent

Wikimedia CommonsShares of drug maker Pfizer Inc. (NYSE: PFE) were halted Wednesday afternoon at $32.29, down about 0.4% from the…

Paul Ausick | Mar 12, 2014 at 11:20 AM EDT

Short Interest Generally Wanes in High-Yield Dividend Stocks

ThinkstockThe short interest data for the final two weeks of February is out, and the results are somewhat surprising when…

Trey Thoelcke | Mar 10, 2014 at 9:05 AM EDT

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

In a new research report, Cowen analysts posted a list of some of the top new datapoints cited at the…

1 … 68 69 70 71 72 … 101

Pfizer : PFE

All Pfizer Articles

The 4 Stocks That Boosted Markets

What a Combined Pfizer and AstraZeneca Would Look Like, and Face

Why Lpath Could Rise 300%

The 4 Stocks That Slammed the Market

FDA Keeps Driving Up Future Cost of Inhalable Insulin

U.S. Companies Park $947 Billion Offshore

Telecoms Liven Up Short Interest in Big Dividend Stocks

J.P. Morgan Says Buy Specialty and Big Pharmaceuticals Now

The 4 Stocks That Pushed Stocks Lower on Monday

The 5 Stocks That Sank Markets on Friday

Analysts’ Top Dow Jones Industrial Dividend Stocks To Buy

Jefferies’ Cheapest Health Care Stocks to Buy

Pfizer Will Appeal Court Decision Regarding Celebrex Reissue Patent

Short Interest Generally Wanes in High-Yield Dividend Stocks

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

QQQI Yields You Almost 14%, but Can It Survive a Dot-Com-Style Recession?

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line

QQQI Yields You Almost 14%, but Can It Survive a Dot-Com-Style Recession?

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

Pfizer : PFE

All Pfizer Articles

The 4 Stocks That Boosted Markets

What a Combined Pfizer and AstraZeneca Would Look Like, and Face

Why Lpath Could Rise 300%

The 4 Stocks That Slammed the Market

FDA Keeps Driving Up Future Cost of Inhalable Insulin

U.S. Companies Park $947 Billion Offshore

Telecoms Liven Up Short Interest in Big Dividend Stocks

J.P. Morgan Says Buy Specialty and Big Pharmaceuticals Now

The 4 Stocks That Pushed Stocks Lower on Monday

The 5 Stocks That Sank Markets on Friday

Analysts’ Top Dow Jones Industrial Dividend Stocks To Buy

Jefferies’ Cheapest Health Care Stocks to Buy

Pfizer Will Appeal Court Decision Regarding Celebrex Reissue Patent

Short Interest Generally Wanes in High-Yield Dividend Stocks

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

QQQI Yields You Almost 14%, but Can It Survive a Dot-Com-Style Recession?

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

Featured Reads

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line